FAQ Library

FAQ Library published on March 6, 2015
Dr. Bart Scott discusses whether you would consider lenalidomide for patients with MDS who do not have deletion 5q.
FAQ Library published on March 6, 2015
Dr. Bart Scott discusses the recent treatments for MDS, how they compare, and the appropriate times to use each individual therapy.
FAQ Library published on March 6, 2015
Dr. Bart Scott discusses the role patient education and communication play in the overall outcome of treatment.
FAQ Library published on January 28, 2015
Dr. Goldberg discusses what factors to consider when implementing the oral agent lenalidomide as a single agent as well as in combination with hypomethylating agents.
FAQ Library published on January 20, 2015
Sandra Kurtin discusses the treatment approach for transfusion-related iron overload in patients with MDS.
FAQ Library published on January 20, 2015
Sandra Kurtin briefly discusses the frequency of 5-q deletion in MDS and the available treatment options.
FAQ Library published on January 20, 2015
Sandra Kurtin briefly discusses the quality of life issues that face adults with newly diagnosed with MDS.
FAQ Library published on January 20, 2015
Sandra Kurtin briefly describes the options available to patients with MDS who do not respond to initial treatment.
FAQ Library published on September 30, 2014
Dr. Nimer discusses the current FDA-approved agents for treating MDS.
FAQ Library published on September 23, 2014
Dr. Goldberg discusses using the IPSS to determine a patient's prognosis and therapeutic regimen.
Page 5 of 6
Results 41 - 50 of 60

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved